ArticleJournal of medical case reports2025
Brown tumor mimicking giant cell tumor in primary hyperparathyroidism: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PersistentMolecular imaging and radionuclide therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDifferentiating brown tumor due to primary hyperparathyroidism from a giant cell tumor remains a clinical challenge. Misdiagnosis may lead to inappropriate oncologic treatment and unnecessary surgical interventions. CASE PRESENTATION: We report the case of a 52-year-old Caucasian white woman of Albanian ethnicity with multiple osteolytic bone lesions and a history of repeated orthopedic surgeries over 5 years. Initial histopathology suggested aneurysmal bone cyst and giant cell tumor, while imaging findings were interpreted as metastatic bone disease, and led to chemotherapy and radiotherapy in the absence of a confirmed primary malignancy. The patient was later referred to our Nuclear Medicine Unit, where a repeat bone scintigraphy indicated metabolic bone disease. A full biochemical evaluation revealed severe hypercalcemia and elevated parathyroid hormone. Parathyroid scintigraphy confirmed a hyperfunctioning parathyroid adenoma. Retrospective review of previous pathology reports supported the diagnosis of brown tumor. The patient underwent successful parathyroidectomy. Biochemical parameters normalized within 3 months postoperatively, and no complications such as hypocalcemia were observed.
conclusionThis case illustrates the importance of early consideration of primary hyperparathyroidism in the differential diagnosis of multifocal lytic bone lesions. Accurate diagnosis requires a multidisciplinary approach combining imaging, histopathology, and biochemical evaluation to prevent misdiagnosis and overtreatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.